Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03876054 · ClinicalTrials.gov registry record
Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator
A clinical trial of Chronic Pain, sponsored by Abbott Medical Devices.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 20
- Study locations
NCT03876054 is a study of Chronic Pain that is actively recruiting participants, run by Abbott Medical Devices. The registered enrollment target is 2,000 participants, above the 766-participant average among 301 other Chronic Pain trials with a reported enrollment target (161% higher). The trial reports 20 study locations across 10 states.
The verdict
NCT03876054, a study of Chronic Pain, is actively recruiting participants, sponsored by Abbott Medical Devices.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The REALITY study is a prospective, post-market, non-randomized, multi-center, single-arm, open-label study intended to collect short- and long-term safety and effectiveness data on various populations implanted with Abbott's neurostimulation systems.
Conditions Studied
Interventions
- DEVICE Spinal cord stimulation (SCS)
- DEVICE Dorsal root ganglion stimulation (DRG)
Study Locations (20)
California
- California Orthopedics & Spine - Larkspur
- Restore Orthopedics & Spine Center - Orange
- Foothills Pain Management Clinic - Pomona
- Pacific Research Institute - Santa Rosa
Minnesota
- Nura - Edina
- Twin Cities Pain Clinic - Edina
- Mayo Clinic - Rochester
New York
- Ainsworth Institute of Pain Management - New York
- Unity Spine Center - Rochester
- The Spine & Pain Institute of New York - Staten Island
Arizona
- Phoenician Centers for Research & Innovation - Phoenix
- Pain Institute of Southern Arizona - Tucson
Illinois
- Rush University Medical Center - Chicago
- University of Chicago - Chicago
Nevada
- Advanced Pain Care - Henderson
- Nevada Advanced Pain Specialists - Reno
Florida
- University of Florida Department of Anesthesia - Gainesville
Indiana
- Goodman Campbell Brain and Spine - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2019-03-13 |
| Est. Completion | 2029-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03876054
The ClinicalTrials.gov registry entry for NCT03876054 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 766-participant average among 301 other Chronic Pain trials with a reported enrollment target (161% higher). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Spinal cord stimulation (SCS) is the first listed.
NCT03876054 reports 20 study locations spanning 10 distinct geographic areas - top geographies include California, Minnesota, New York.
Frequently Asked Questions
What is clinical trial NCT03876054 about?
NCT03876054 is a clinical study titled "Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator". The REALITY study is a prospective, post-market, non-randomized, multi-center, single-arm, open-label study intended to collect short- and long-term safety and effectiveness data on various populations implanted with Abbott's neurostimulation systems.
What is the current status of trial NCT03876054?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2019-03-13. Estimated completion is 2029-12.
What conditions does trial NCT03876054 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT03876054?
The interventions under investigation include: Spinal cord stimulation (SCS) (DEVICE), Dorsal root ganglion stimulation (DRG) (DEVICE).
Who is sponsoring clinical trial NCT03876054?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03876054 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.